SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 183 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $1,551,000 | -53.0% | 52,416 | -56.4% | 0.05% | -34.6% |
Q4 2016 | $3,301,000 | -54.7% | 120,331 | +1.3% | 0.08% | -47.3% |
Q3 2016 | $7,293,000 | +73.2% | 118,753 | -46.2% | 0.15% | +102.7% |
Q2 2016 | $4,210,000 | +104.9% | 220,744 | +109.6% | 0.07% | +102.8% |
Q1 2016 | $2,055,000 | -63.2% | 105,318 | -27.2% | 0.04% | -37.9% |
Q4 2015 | $5,580,000 | +57.5% | 144,629 | +31.1% | 0.06% | +70.6% |
Q3 2015 | $3,542,000 | +42.2% | 110,296 | +34.8% | 0.03% | +47.8% |
Q2 2015 | $2,491,000 | +792.8% | 81,852 | +289.5% | 0.02% | +666.7% |
Q1 2015 | $279,000 | -92.7% | 21,015 | -92.0% | 0.00% | -87.0% |
Q4 2014 | $3,805,000 | -8.6% | 262,973 | +33.4% | 0.02% | +9.5% |
Q3 2014 | $4,161,000 | -19.4% | 197,200 | +13.8% | 0.02% | -16.0% |
Q2 2014 | $5,161,000 | +31.3% | 173,255 | +5.9% | 0.02% | +13.6% |
Q1 2014 | $3,930,000 | +508.4% | 163,547 | +415.9% | 0.02% | +633.3% |
Q4 2013 | $646,000 | -38.4% | 31,700 | +42.8% | 0.00% | -50.0% |
Q3 2013 | $1,049,000 | +25.9% | 22,200 | +1.4% | 0.01% | +20.0% |
Q2 2013 | $833,000 | – | 21,900 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |